Free Design Audit Available - Click Here for Details

FDA clears Hyperfine AI-powered brain imaging software

Hyperfine (Nasdaq:HYPR) announced today that the FDA cleared its ninth-generation AI-powered Swoop system software.

This clearance comes just months after the company launched its eight-generation software in January. The advanced software significantly reduces scan times across multiple magnetic resonance (MR) brain imaging sequences without sacrificing quality.

Guilford, Connecticut-based Hyperfine said in a news release that scan time reductions may enable Swoop images to speed up the diagnostic process in acute care settings. This could prove crucial for time-sensitive medical conditions like stroke. Reducing the overall acquisition time for sequences can also decrease the negative impact of patient motion on image quality.

Sign up for Blog Updates